Preprint: Ali, M., & Campbell, P. PREdictors of COVID-19 OUtcomeS (PRECIOUS): Protocol for a systematic review-informed individual participant data meta-analysis of long-term outcomes after COVID-19. (2025, September 8). doi: 10.31219/osf.io/jyf9b_v3

Preprint: Preethy S, Yamamoto N, Cherian KM, Premsekar R, Levy GA, Senthilkumar R, Abraham S. Reduction in myocardial fibrosis in MDX mice on oral consumption of Aureobasidium Pullulans produced Neu REFIX Beta-glucans; holds potential as an adjuvant in managing post-transplantation organ fibrosis. BioRixv. 2023. 10.1101/2023.09.25.559276. doi: 10.1101/2023.09.25.559276

Preprint: Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Koji Ichiyama, Naoki Yamamoto, Hiroto Kawashima, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham. Improvement in Expanded Disability Status Scale (EDSS) and anti-inflammatory parameters in patients with multiple sclerosis following oral consumption of N-163 strain of Aureobasidium pullulans produced beta glucan in a pilot clinical study. medRxiv 2023.05.14.23289953v2; doi: 10.1101/2023.05.14.23289953

Preprint: Kadalraja Raghavan, Thanasekar Sivakumar, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham. Efficacy of N-163 strain of Aureobasidium pullulans-produced beta-glucan in improving muscle strength and function in patients with Duchenne muscular dystrophy; Results of a 6-month non-randomised open-label linear clinical trial. medRxiv 2023.04.29.23289260v1; doi: 10.1101/2023.04.29.23289260

Preprint: Chockanathan Vetrievel, Allimuthu Nithyanandam, Subramaniam Srinivasan, Sudhakar S Bharatidasan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham. Evaluation of the disease modifying effects of Aureobasidium pullulans AFO 202 strain produced Beta Glucan in Parkinsons disease Results of a pilot clinical study. medRxiv 2023.04.14.23288571v1; doi: 10.1101/2023.04.14.23288571

 

In Print in indexed and peer-reviewed Journals

Inprint: Vaddi S, Senthilkumar R, Horiguchi A, Reddy DSK, Rajmohan M, Karthick R, Preethy S, Abraham SJK, et al. Comparative analysis of maximal urinary flow rate (Qmax) across different treatment modalities for male urethral stricture and its role as a predictor of long-term therapeutic outcome. Bladder. 2025. (In print).